Masao Yagi

Dr. Masao Yagi

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2002 in Audiology and Neurotology
Verified
Journal Article
Closed access
Sho KanzakiSho Kanzaki
Sho Kanzaki
KKKohei Kawamoto
Kohei Kawamoto
SOSeung-Ha Oh
Seung-Ha Oh
TSTimo Stöver
Timo Stöver
MSMitsuya Suzuki
Mitsuya Suzuki
YRYehoash Raphael
Yehoash Raphael
Inner ear disease due to hair cell loss is common, and no restorative treatments for the balance and hearing impairment are currently available. To develop clinical means for enhancing protection and regeneration in the inner ear, it is necessary to understand the molecular basis for hereditary and acquired deafness and vestibular disorders. One approach is to identify and characterize genes that regulate protection or repair in other systems. For that purpose, we have used the differential display assay and compared gene expression between normal and acoustically traumatized inner ears of chicks. Several chick cDNAs that were identified are considered as candidates for roles in the reparative process that follows trauma in the basilar papilla. The mammalian vestibular epithelium has a limited regenerative capability. To identify genes that may participate in the regenerative response, we have used gene arrays profiling, comparing normal to drug-traumatized vestibular epithelia. We identified several genes that are differentially expressed in traumatized vestibular epithelium, including several insulin-like growth factor-I binding proteins. To use this molecular knowledge for enhancing protection and repair in the organ of Corti, it is necessary to overexpress the genes of choice in the inner ear. Using viral-mediated gene transfer, we overexpressed transgenic glial cell line-derived neurotrophic factor and demonstrated a robust protective effect against acoustic and ototoxic inner ear trauma. Future identification of the genes that are important for protection and regeneration, along with improved gene transfer technology, will allow the use of gene therapy for treating hereditary and environmental inner ear disease.

30 June 2025 in Head and Neck Pathology
Verified
Journal Article
Open access
PDF file
YNYuri Noda
Yuri Noda
MYMasao Yagi
Masao Yagi
KTKoji Tsuta
Koji Tsuta
Purpose: A significant proportion of patients with head and neck squamous cell carcinoma (HNSCC) are ineligible for immune checkpoint inhibitors (ICIs) because of low programmed cell death protein-ligand 1 (PD-L1) expression. The therapeutic potential of B7-H4 ( VTCN1 ) was investigated using immunohistochemistry (IHC) and spatial transcriptomics (ST). Methods: IHC analysis of B7-H4, PD-L1, CD3, CD4, and CD8 was performed using a tissue microarray [94 HNSCC, 94 adjacent squamous intraepithelial neoplasia (SIN), and 69 adjacent normal oral mucosa (NOM) samples]. B7-H4 and PD-L1 expression levels were assessed using tumor cell score (TC; positive, TC > 1%), immune cell score, and combined positive score. ST was performed on six HNSCCs with paired SINs and NOMs to confirm the expression and distribution of B7-H4 ( CTVN1 ), PD-L1 ( CD274 ), CD4 ( DC4A ), and CD8 ( CD8 ). Results: In HNSCCs, TCs revealed a mutually exclusive B7-H4/PD-L1 expression pattern in 55% of samples ( p < 0.05). B7-H4 positive TCs were more frequent in HNSCCs (79%) than in SINs (10%) and NOMs (2%). ST analysis confirmed mutually exclusive VTCN1 / CD274 upregulation in 83% of samples ( n = 6) and demonstrated co-localization of B7-H4 protein and VTCN1 in IHC-positive areas. B7-H4 was significantly correlated with low-CD8 + T-cell infiltration ( n = 94, p = 0.009), and CD8A mRNA was down-regulated in the VTCN1 + area compared with that in the VTCN1 + area. Conclusion: B7-H4 is a promising antibody–drug conjugate target in ICI-resistant HNSCC. IHC combined with TCs enabled the reliable assessment of B7-H4, given its co-localization with VTCN1 in IHC-positive areas and association with low-CD8 + T-cells.

1 October 2018 in International Journal of Surgery
Verified
Journal Article
Closed access
KSKensuke Suzuki
Kensuke Suzuki
MSMinaki Shimizu
Minaki Shimizu
TSTomofumi Sakagami
Tomofumi Sakagami
MYMasao Yagi
Masao Yagi
TFTakuo Fujisawa
Takuo Fujisawa
HIHiroshi Iwai
Hiroshi Iwai
The aim of this study was to evaluate the efficacy of the new energy-based device Thunderbeat in neck dissection (ND) for head and neck cancer. We retrospectively examined 95 consecutive patients who underwent ND for head and neck squamous cell carcinoma between April 2013 and March 2018. The patients were divided into three groups: ND without the energy-based device (control group), ND using the LigaSure Small Jaw (LS group), and ND using the Thunderbeat Open Fine Jaw (TB group). The outcomes were compared among the three groups, as measured by the duration of ND (dissection time), blood loss during ND, and postoperative complications. We also analyzed the factors that may influence dissection time using multivariate analysis. Compared to the control group, dissection time was found to be significantly shorter in both energy-based device groups (LS group and TB group) (96.4, 71.1, and 66.0 min, respectively, p = 0.0015) by univariate analysis. Blood loss during ND did not differ significantly among the three groups. Multivariate analysis showed that ND using the Thunderbeat as well as elderly patients (70 years and over), less extensive surgery (3 or fewer neck levels), and absence of extracapsular invasion were independently and significantly associated with shorter dissection time (p = 0.0069, 0.0337, <0.0001, and 0.0015, respectively). The incidence of postoperative complications in the LS group (20%) tended to be higher than those in the other groups (5.6% in the control group and 3.4% in the TB group), although the differences were not significant. ND for head and neck cancers using the Thunderbeat is a safe and reliable method in terms of duration of dissection without increasing postoperative complications.

1 March 2021 in Sinusitis
Verified
Journal Article
Open access
PDF file
YYyasutaka yun
yasutaka yun
MYMasao Yagi
Masao Yagi
智阪智史 阪上
智史 阪上
SSShunsuuke Sawada
Shunsuuke Sawada
YKYuka Kojima
Yuka Kojima
HIHiroshi Iwai
Hiroshi Iwai
Odontogenic maxillary sinusitis (OMS) is a disease in which inflammation from the teeth extend into the maxillary sinus, causing symptoms of unilateral sinusitis. OMS can recur, with some being resistant to antibiotics. In intractable cases, exodontia and endoscopic sinus surgery (ESS) are necessary treatments. Here we report our analysis on the indications for surgical intervention in cases diagnosed with and treated as OMS. We retrospectively examined 186 patients who were diagnosed with sinusitis on a computed tomography (CT) scan. For cases diagnosed with OMS, the site of the causative tooth and the presence or absence of oroantral fistula to the maxillary sinus was examined. In addition, we analyzed the therapeutic efficacy of the initial treatment of antibiotics, and what the indications were for ESS. Among the patients examined, OMS was diagnosed in 44 cases (23.6%). In 14 out of 20 cases that underwent a post-medical treatment CT scan, OMS found to be treatment-resistant. Of these 14 cases, 12 (88%) had oroantral fistulae to the maxillary sinus. In all cases where exodontia, fistula closure surgery, and endoscopic sinus surgery (ESS) were performed, the fistula disappeared and the shadow of inflammation in the paranasal sinus improved. In OMS with oroantral fistula, ESS, exodontia, and fistula closure should be recommended over medication such as macrolide therapy.

26 December 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MYMasao Yagi
Masao Yagi
智阪智史 阪上
智史 阪上
MSMinaki Shimizu
Minaki Shimizu
YOYuhei Ogino
Yuhei Ogino
MMMizuki Morita
Mizuki Morita
HIHiroshi Iwai
Hiroshi Iwai
Background/Objectives: Parotid surgery is generally performed with the naked eye or using surgical loupes. However, this approach has technical disadvantages. Therefore, this study aimed to compare the use of an exoscope with that of loupe for parotidectomies. Methods: A retrospective review of patients who underwent partial parotidectomies for parotid tumors was conducted. We examined the approach (anterograde/retrograde), tumor localization (superficial/deep), operative time, volume of intraoperative blood loss, and postoperative complications occurring within 6 months. Results: Overall, 174 patients underwent parotidectomies (90 in the exoscope group, 84 in the loupe group). In parotidectomies using the anterograde approach, the exoscope group had significantly fewer reports of facial nerve palsy than the loupe group. Parotidectomy-related complications other than facial palsy were significantly fewer in the exoscope group. However, the operation time was significantly longer in the exoscope group than in the loupe group. Conclusions: An ORBEYETM exoscope provides a magnified view of the surgical field, leading to more accurate operations in parotid surgery and potentially fewer complications.

10 September 2025 in Oral and Maxillofacial Surgery
Verified
Journal Article
Open access
PDF file
MYMasao Yagi
Masao Yagi
MMMizuki Morita
Mizuki Morita
TSTomofumi Sakagami
Tomofumi Sakagami
MSMinaki Shimizu
Minaki Shimizu
TUToshiki Utsunomiya
Toshiki Utsunomiya
HIHiroshi Iwai
Hiroshi Iwai
Purpose For submandibular gland resection, conventional surgery with the naked eye remains the standard. With its excellent automatic focus and high magnification, the ORBEYE 3D exoscope enables precise submandibular gland resection with less stress. Therefore, we aimed to examine the usefulness of the exoscope in submandibular gland resection. Methods This retrospective study involved 12 patients who underwent submandibular gland resection with the ORBEYE exoscope at the Department of Head and Neck Surgery and Otorhinolaryngology at Kansai Medical University from April 2021 to March 2024. Surgical outcomes were retrospectively reviewed. Results The mean age of the patients (six women and six men) was 58.5 (23–83) years. The final histopathology showed pleomorphic adenoma in eight patients, non-sebaceous-type lymphadenoma and carcinoma ex pleomorphic adenoma in one patient each, and sialolithiasis with chronic inflammation in two patients. We performed facial artery and vein sparing in all patients except one, in whom level I neck dissection, including submandibular gland excision, was performed. We identified the marginal mandibular branches of the facial, hypoglossal, and lingual nerves, as well as the submandibular duct in all patients. There were no postoperative complications in any of the patients. The mean operative time was 104 (80–129) min. The mean blood volume lost was 20 (5–43) mL. Conclusion Using the ORBEYE exoscope in submandibular gland resection will contribute to preserving the mandibular marginal branch of the facial and lingual nerves and facial and artery veins, and visualizing the submandibular ducts, which are important structures surrounding the submandibular gland.